JINGHUA PHARM released its first-quarter performance, with a net profit attributable to the parent company of 62.2197 million yuan, a decrease of 12.47%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, JINGHUA PHARM (002349.SZ) released its first-quarter report for 2025, showing an operating income of 364 million yuan, a year-on-year decrease of 0.98%. The net profit attributable to shareholders of the listed company was 62.2197 million yuan, a year-on-year decrease of 12.47%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 60.3491 million yuan, a year-on-year decrease of 8.30%. The basic earnings per share were 0.0764 yuan
